Login / Signup

Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients.

Roselie E AchtenJudith L ThijsChantal van LuijkEdward F KnolEveline DelemarreMarlies de GraafDaphne S BakkerJoke H de BoerFemke Van WijkMarjolein de Bruin-Weller
Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2022)
Keyphrases
  • atopic dermatitis
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • high intensity
  • early onset
  • patient reported